Southpoint Capital Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.8M Buy
+1,709,069
New +$29.8M 0.75% 34